273 related articles for article (PubMed ID: 1848315)
1. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
Yasumoto S; Taniguchi A; Sohma K
J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
3. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
5. An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells.
Liu Y; Li JZ; Yuan XH; Adler-Storthz K; Che Z
Virus Genes; 2002; 24(1):29-37. PubMed ID: 11928986
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
7. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18.
Romanczuk H; Villa LL; Schlegel R; Howley PM
J Virol; 1991 May; 65(5):2739-44. PubMed ID: 1850048
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway.
Gaiotti D; Chung J; Iglesias M; Nees M; Baker PD; Evans CH; Woodworth CD
Mol Carcinog; 2000 Feb; 27(2):97-109. PubMed ID: 10657902
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
10. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity.
Lembo D; Donalisio M; De Andrea M; Cornaglia M; Scutera S; Musso T; Landolfo S
FASEB J; 2006 Jan; 20(1):148-50. PubMed ID: 16254045
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells.
Hu G; Liu W; Mendelsohn J; Ellis LM; Radinsky R; Andreeff M; Deisseroth AB
J Natl Cancer Inst; 1997 Sep; 89(17):1271-6. PubMed ID: 9293917
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.
Pei XF
Carcinogenesis; 1996 Jul; 17(7):1395-401. PubMed ID: 8706240
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
[TBL] [Abstract][Full Text] [Related]
14. Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6/E7 oncogene expression.
Finzer P; Ventz R; Kuntzen C; Seibert N; Soto U; Rösl F
Virology; 2002 Dec; 304(2):265-73. PubMed ID: 12504567
[TBL] [Abstract][Full Text] [Related]
15. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
16. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.
Stünkel W; Bernard HU
J Virol; 1999 Mar; 73(3):1918-30. PubMed ID: 9971771
[TBL] [Abstract][Full Text] [Related]
17. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells.
Kyo S; Klumpp DJ; Inoue M; Kanaya T; Laimins LA
J Gen Virol; 1997 Feb; 78 ( Pt 2)():401-11. PubMed ID: 9018063
[TBL] [Abstract][Full Text] [Related]
18. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16.
Su PF; Chiang SY; Wu CW; Wu FY
J Virol; 2000 Mar; 74(5):2459-65. PubMed ID: 10666281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
